We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Down 41% over five years while the S&P 500 rose 72%; up 28% in the past year.
“The segment’s operating margin decreased primarily due to a reduction in volume leverage.”
| Latest filing | 10-Q, Nov 6 |
Fri Nov 13: Ex-dividend, $0.08 a shareAt the open. Pays Nov 23.
After its last 4 reports it closed -3.0% on average, higher 2 of 4 times.
Below Averagefor quality, not price, 7 of 14 chart checks firingWhat the Quality Score means
TECH is #141 of 281 by Quality Score.
| Rank | Stock | Quality Score |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 141 |
Net income over four quarters: TECH $172M, RGEN -$11.8M.
Expected to report Tue Feb 9, after the close (in 91 days).
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
| Reported | Gap | Reaction | 5 days |
|---|---|---|---|
| Aug 12, 2026 | -0.0% | +0.1% | +0.1% |
| May 6, 2026 | 0.0% | -16.4% | -16.3% |
| Feb 4, 2026 | +3.2% | +6.3% | +0.3% |
Sales grew in two of the last three years, to $1.2B in 2026. It made a profit in each of the four years.
RSI 62.4, MACD above signal, above both averages. Not scored.
4 trades disclosed in the last six months. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: TECH is under 0.1% of IVV, under 0.1% of SPY, and under 0.1% of VOO, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026 (SPY's as filed by IVV).
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
“Although our segments both generally operate in highly competitive markets, it is difficult to determine our competitive position, either in the aggregate or by segment, since none of our competitors offer all of the same product and service lines or serve all of the same markets as the Company or its segments.”
TECH scores 0 today, which Breakaway calls Below Average. It is #141 of 281 in Biotech by Quality Score, with 7 of 14 chart checks firing. Down 41% over five years while the S&P 500 rose 72%; up 28% in the past year. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
TECH scores 0 today, which Breakaway calls Below Average (0 to 5). That is #141 of 281 in Biotech by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind TECH's 0.
Expected to report Tue Feb 9, after the close, a date Breakaway expects from the company's usual timing; the company has not confirmed it. TECH closed higher after 2 of its last 4 reports. Past behavior, not a forecast.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Insider and Congress trades, the chart, and the financials, in one score.
See it live, free until Thursday morning. No account. No card. Then keep going with a free account.